Bronchial Hyperreactivity Assessment
Objective: Measurement of bronchial hyperreactivity as a marker of asthma features in response to HDM (house dust mite) allergen challenge
This is a Bronchial Hyperreactivity Assessment protocol using mouse as the model organism. The procedure involves 3 procedural steps, 1 equipment items, 2 materials. Extracted from a 2009 paper published in Nature Medicine.
Model and subjects
mouse • Not specified in provided text • unknown • Not specified in provided text • Not specified in provided text
Study window
Estimated timing pending
Core workflow
HDM allergen challenge • Bronchial hyperreactivity assessment • TLR4 antagonist treatment
Primary readouts
- Bronchial hyperreactivity
- Allergic airway inflammation
- DC activation in the lung
- Effector T helper responses
Key equipment and reagents
Use this page as an execution guide, then fall back to the source paper whenever you need exact exclusions, dosing details, or assay-specific caveats.
Confirm first
- Verify the animal model, intervention setup, and collection timepoints against the source paper.
- Check that every direct vendor link matches the exact specification your lab plans to run.
Use the page like this
- Work through the protocol steps in order and use the inline vendor chips only when you need to source or verify an item.
- Jump to Experimental Context for readouts, data shape, and analysis flow before planning downstream analysis.
Protocol Steps
Start here. The step list is optimized for running the experiment, with direct vendor links available inline when you need to source a cited item.
HDM allergen challenge
Mice were exposed to house dust mite allergen via inhalation to induce allergic airway inflammation and asthma-like features
Note: This challenge was used to establish HDM-driven allergic airway inflammation
View evidence from paper
“TLR4 expression on radioresistant lung structural cells is required and sufficient for DC activation in the lung and for priming of effector T helper responses to HDM”
Bronchial hyperreactivity assessment
Measurement of bronchial hyperreactivity as a salient feature of asthma in response to HDM challenge
Note: Bronchial hyperreactivity was one of the key asthma features evaluated
View evidence from paper
“inhalation of a TLR4 antagonist to target exposed epithelial cells suppressed the salient features of asthma including bronchial hyperreactivity”
TLR4 antagonist treatment
Administration of TLR4 antagonist via inhalation to target exposed epithelial cells
Note: Treatment was designed to suppress asthma features by targeting epithelial cells
View evidence from paper
“inhalation of a TLR4 antagonist to target exposed epithelial cells suppressed the salient features of asthma including bronchial hyperreactivity”